A Phase 1 Study Evaluating the Safety, Tolerability and Efficacy of AMG 119 in Subjects With RR SCLC
NCT03392064
·
clinicaltrials.gov ↗
PHASE1
Phase
SUSPENDED
Status
6
Enrollment
INDUSTRY
Sponsor class
Stopped
Study on enrollment hold, may potentially resume. No active subjects on trial.
Conditions
Small Cell Lung Cancer
Interventions
BIOLOGICAL:
AMG 119
Sponsor
Amgen